NRAS and melanoma: In mucosal melanomas, apart from driver mutations affecting the MAPK pathway (e.g., NRAS, BRAF, NF1, and KIT), mutations in CTNNB1 affecting Wnt/β-catenin pathway activation have also been reported (103, 105).